e-ISSN: Pending
Negative / Null Result ReportOpen accessMedicine· cited by 41

Effect of intravenous clarithromycin in patients with sepsis, respiratory and multiple organ dysfunction syndrome: a randomized clinical trial

Eleni Karakike; Brendon P. Scicluna; Maria Roumpoutsou; Ioannis Mitrou; Niki Karampela; Athanasios Karageorgos; Konstantinos Psaroulis; Eleni Massa · 2022 · Critical Care

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

BACKGROUND: Clarithromycin may act as immune-regulating treatment in sepsis and acute respiratory dysfunction syndrome. However, clinical evidence remains inconclusive. We aimed to evaluate whether clarithromycin improves 28-day mortality among patients with sepsis, respiratory and multiple organ dysfunction syndrome. METHODS: We conducted a multicenter, randomized, clinical trial in patients with sepsis. Participants with ratio of partial oxygen pressure to fraction of inspired oxygen less than 200 and more than 3 SOFA points from systems other than the respiratory function were enrolled betw

Abstract by Eleni Karakike; Brendon P. Scicluna; Maria Roumpoutsou; Ioannis Mitrou; Niki Karampela; Athanasios Karageorgos; Konstantinos Psaroulis; Eleni Massa, Critical Care (2022) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: OpenAlex · DOI 10.1186/s13054-022-04055-4